0001209191-19-028873.txt : 20190510
0001209191-19-028873.hdr.sgml : 20190510
20190510161042
ACCESSION NUMBER: 0001209191-19-028873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190508
FILED AS OF DATE: 20190510
DATE AS OF CHANGE: 20190510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danziger Asaf
CENTRAL INDEX KEY: 0001654435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19814993
MAIL ADDRESS:
STREET 1: 5 NACHUM CHAT ST.
CITY: TIRAT HACARMEL
STATE: L3
ZIP: 5112302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-08
0
0001645113
NovoCure Ltd
NVCR
0001654435
Danziger Asaf
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
1
0
0
Chief Executive Officer
Options to Buy Ordinary Shares
47.56
2019-05-08
4
A
0
115060
0.00
A
2029-05-08
Ordinary Shares
115060
115060
D
Options to Buy Ordinary Shares
47.56
2019-05-08
4
A
0
35000
0.00
A
2029-05-08
Ordinary Shares
35000
35000
D
Options to buy 115,060 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $59.45 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Danziger has been continuously employed by the Company through May 8, 2022.
Options to buy 35,000 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $71.34 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Danziger has been continuously employed by the Company through May 8, 2022.
By: /s/ Kimberly Burke, Attorney in fact for Asaf Danziger
2019-05-10